Understanding Value Stocks
A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples are good base indicators that the company is undervalued and can most likely be labelled as a value stock.
The following stocks are considered to be notable value stocks in the healthcare sector:
- Nuwellis NUWE - P/E: 0.02
- Exicure XCUR - P/E: 0.33
- Acorda Therapeutics ACOR - P/E: 3.69
- Prenetics Global PRE - P/E: 0.24
- Ocuphire Pharma OCUP - P/E: 2.03
Most recently, Nuwellis reported earnings per share at $-1.81, whereas in Q2 earnings per share sat at $-3.65. Exicure has reported Q2 earnings per share at $-0.68, which has increased by 2.86% compared to Q1, which was -0.7. Acorda Therapeutics's earnings per share for Q3 sits at $-7.16, whereas in Q2, they were at -7.55. Prenetics Global looks to be undervalued. It possesses an EPS of $-0.05, which has not changed since last quarter (Q2). Most recently, the company reported a dividend yield of 1.99%, which has decreased by 0.02% from last quarter's yield of 2.01%.
Ocuphire Pharma saw an increase in earnings per share from -0.24 in Q2 to $0.25 now.
The Significance: A value stock may need some time to rebound from its undervalued position. The risk of investing in a value stock is that this emergence may never materialize.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.